-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
8 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$44.20 M
Intra-Cellular Therapies, Inc. Insider Transactions
Intra-Cellular Therapies, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Durgam Suresh K.
EVP, Chief Medical Officer |
Sell | 872 @ $65.89 | $57,456 | 20,464 | 03/11/2024 | 03/11/2024 | |
|
Durgam Suresh K.
EVP, Chief Medical Officer |
Sell | 661 @ $66.96 | $44,261 | 19,803 | 03/11/2024 | 03/11/2024 | |
|
Mates Sharon
CEO |
Sell | 31,958 @ $66.38 | $2.12 M | 1,059,063 | 03/07/2024 | 03/11/2024 | |
|
Mates Sharon
CEO |
Sell | 8,754 @ $66.93 | $585,905 | 1,050,309 | 03/07/2024 | 03/11/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 6,514 @ $66.26 | $431,618 | 6,618 | 03/07/2024 | 03/11/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 6,618 @ $66.93 | $442,943 | 0 | 03/07/2024 | 03/11/2024 | |
|
Halstead Michael
EVP and General Counsel |
Sell | 12,912 @ $66.14 | $854,000 | 220 | 03/07/2024 | 03/11/2024 | |
|
Halstead Michael
EVP and General Counsel |
Sell | 220 @ $66.81 | $14,698 | 0 | 03/07/2024 | 03/11/2024 | |
|
Neumann Mark
EVP, Chief Commercial Officer |
Sell | 8,636 @ $66.37 | $573,171 | 34,196 | 03/07/2024 | 03/11/2024 | |
|
Neumann Mark
EVP, Chief Commercial Officer |
Sell | 4,496 @ $66.95 | $301,007 | 29,700 | 03/07/2024 | 03/11/2024 | |
|
Durgam Suresh K.
EVP, Chief Medical Officer |
Sell | 3,728 @ $66.34 | $247,316 | 18,892 | 03/07/2024 | 03/11/2024 | |
|
Durgam Suresh K.
EVP, Chief Medical Officer |
Sell | 2,722 @ $66.86 | $181,993 | 16,170 | 03/07/2024 | 03/11/2024 | |
|
VAN NOSTRAND ROBERT L
Director |
Sell | 9,651 @ $72.71 | $701,724 | 19,960 | 02/27/2024 | 02/28/2024 | |
|
VAN NOSTRAND ROBERT L
Director |
Sell | 10,349 @ $73.14 | $756,926 | 9,611 | 02/27/2024 | 02/28/2024 | |
|
Halstead Michael
EVP and General Counsel |
Sell | 300 @ $68.54 | $20,562 | 7,607 | 02/26/2024 | 02/27/2024 | |
|
Halstead Michael
EVP and General Counsel |
Sell | 7,215 @ $69.54 | $501,731 | 392 | 02/26/2024 | 02/27/2024 | |
|
Halstead Michael
EVP and General Counsel |
Sell | 392 @ $70.13 | $27,491 | 0 | 02/26/2024 | 02/27/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 300 @ $68.33 | $20,499 | 7,155 | 02/26/2024 | 02/27/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 5,282 @ $69.47 | $366,941 | 600 | 02/26/2024 | 02/27/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 6,867 @ $69.38 | $476,432 | 288 | 02/26/2024 | 02/27/2024 |
Intra-Cellular Therapies, Inc. Congressional Trades History
| Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
|---|---|---|---|---|---|
| $82.47 | Sale | $1,001 - $15,000 | 07/09/2024 | 06/21/2024 |
Intra-Cellular Therapies, Inc. Frequently Asked Questions
-
Who is on Intra-Cellular Therapies, Inc.'s Insider Roster?
The list of insiders at Intra-Cellular Therapies, Inc. includes MARCUS JOEL S, Neumann Mark, Durgam Suresh K., Mates Sharon, Hineline Lawrence J., Halstead Michael, VAN NOSTRAND ROBERT L, RIGGS RORY B.
-
How much insider selling is happening at Intra-Cellular Therapies, Inc.?
Insiders have sold a total of 607,885 Intra-Cellular Therapies, Inc. shares in the last 12 months for a total of 44.20 M sold.
-
Which Intra-Cellular Therapies, Inc. insiders have been selling company stock?
The following insiders have sold Intra-Cellular Therapies, Inc. shares in the last 12 months: MARCUS JOEL S ($1.79 M), Neumann Mark ($3.32 M), Durgam Suresh K. ($864,193), Mates Sharon ($26.85 M), Hineline Lawrence J. ($2.47 M), Halstead Michael ($5.60 M), VAN NOSTRAND ROBERT L ($2.98 M), RIGGS RORY B ($337,193),